Colorcon has announced a new starch tabletting excipient, StarTab, designed specifically for the direct compression process.
In recent years, formulation scientists have become increasingly interested in direct compression (DC) tablet manufacturing processes. In response to this market trend, Colorcon has developed StarTab Directly Compressible Starch.
This represents a breakthrough for the DC process, where StarTab’s unique particle size and shape provides excellent flow and superior compressibility on high-speed compression machines; enabling formulation scientists to simplify tablet formulation and manufacturing.
StarTab also plays an important role in enhancing the stability of moisture sensitive active pharmaceutical ingredients.
Dr Ali Rajabi-Siahboomi, CSO at Colorcon, said: “Through extensive market and scientific research using particle engineering, we designed StarTab to be used as a single ingredient for the direct compression process. As StarTab uses a material that is accepted by regulatory bodies across the world, there are no barriers to adoption of the product.”
Jayesh Parmar, General Manager, Colorcon said: “The launch of this latest innovation meets the needs of the pharmaceutical industry for direct compression and is an advanced addition complementing the portfolio of solutions we provide through our starch product line.”
This latest launch demonstrates Colorcon’s continued leadership in bringing to market speciality excipients, as well as film coating systems, with improved convenience marked by speed and efficiency, cost savings and dependable performance.